Short answer · Medically reviewed summary · Last updated: 2026-04-08
TL;DR: Fuchs dystrophy, also known as Fuchs endothelial corneal dystrophy (FECD), is a progressive eye condition characterized by the deterioration of the corneal endothelium. While medical professionals most commonly use the term "Fuchs endothelial corneal dystrophy," you may encounter it in older literature or international contexts as Fuchs' dystrophy or Fuchs' epithelial-endothelial dystrophy. Why does Fuchs dystrophy have multiple names? The naming of Fuchs dystrophy reflects its historical classification and the evolving understanding of its pathology.
1 people with Fuchs dystrophy have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Fuchs dystrophy, also known as Fuchs endothelial corneal dystrophy (FECD), is a progressive eye condition characterized by the deterioration of the corneal endothelium. While medical professionals most commonly use the term "Fuchs endothelial corneal dystrophy," you may encounter it in older literature or international contexts as Fuchs' dystrophy or Fuchs' epithelial-endothelial dystrophy.
The naming of Fuchs dystrophy reflects its historical classification and the evolving understanding of its pathology. The condition was first described by Austrian ophthalmologist Ernst Fuchs in 1910. Early nomenclature often included "epithelial-endothelial" to describe the visual changes seen in both layers of the cornea. As clinical research advanced, it became clear that the primary defect originates in the endothelial layer, leading to the current preference for the term Fuchs endothelial corneal dystrophy. In some older medical records or non-English literature, you may still see variations that include the possessive "Fuchs’" or older descriptive terms that do not reflect the current consensus on the disease mechanism.
When searching for information or reviewing your medical records, you may encounter several terms used interchangeably. Understanding these synonyms is vital for navigating clinical literature and connecting with the 99 members of the Fuchs dystrophy community on DiseaseMaps.org. Common terms include:
Standardized medical coding ensures consistency across global healthcare systems. In the International Classification of Diseases (ICD-10 and ICD-11), Fuchs dystrophy is typically classified under corneal dystrophies. The Online Mendelian Inheritance in Man (OMIM) database, which catalogs genetic conditions, identifies early-onset forms of the disease under specific entry numbers (e.g., OMIM #136800 for FECD1), reflecting the hereditary nature of many cases. Orphanet, the reference portal for rare diseases, uses the term Fuchs endothelial corneal dystrophy to ensure accurate tracking across international research registries.
Using the correct terminology—specifically Fuchs endothelial corneal dystrophy—helps patients access the most relevant research and clinical trial information. Because Fuchs dystrophy is a progressive condition, clarity in your medical records is essential for tracking the severity of endothelial cell loss over time. Whether your doctor refers to it by its abbreviation, FECD, or the full diagnostic name, the clinical management remains focused on monitoring corneal thickness and endothelial cell count.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding your health conditions.